SCHEMBL16002986

SCHEMBL16002986

CNC1CCN(C(=O)c2ccccc2N(C)C)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
KMT2A Q03164 3/20 0.47
MAPT P10636 2/20 0.47
MEN1 O00255 2/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
POLB P06746 2/20 0.45
TP53BP1 Q12888 1/20 0.44
L3MBTL3 Q96JM7 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TDP1 Q9NUW8 2/20 0.44
SYK P43405 1/20 0.44
EPHX1 P07099 1/20 0.43
RAB9A P51151 1/20 0.43
LMNA P02545 1/20 0.42
EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16000490 0.86 KMT2A (0.48) ALDH1A1KMT2AMAPTMEN1MAPK1
SCHEMBL10293586 0.81 MGLL (0.54) ALDH1A1KMT2AHTTGAATSHR
SCHEMBL28292405 0.80 HSD11B1 (0.55) ALDH1A1KMT2APOLBTP53BP1L3MBTL3
SCHEMBL16002961 0.80 RAB9A (0.67) ALDH1A1KMT2AMEN1TP53GAA
SCHEMBL13779950 0.78 L3MBTL1 (0.60) ALDH1A1KMT2AMAPTMEN1MAPK1
SCHEMBL16003041 0.78 HTT (0.65) ALDH1A1KMT2AHTTGAATSHR
SCHEMBL16002915 0.78 ALDH1A1 (0.57) ALDH1A1KMT2AMEN1HTTTP53
SCHEMBL7243324 0.77 CYP2C9 (0.70) ALDH1A1KMT2AMEN1HTTSMN1; SMN2
SCHEMBL16002964 0.77 HSD11B1 (0.59) ALDH1A1KMT2APOLBTP53BP1L3MBTL3
SCHEMBL14085268 0.77 RXFP1 (0.60) ALDH1A1KMT2AMAPTMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9145391-B2 Bipyridylaminopyridines as Syk inhibitors MERCK SHARP & DOHME CORP. (US) 2015-09-29 US disclosed
US-20140249130-A1 BIPYRIDYLAMINOPYRIDINES AS SYK INHIBITORS MERCK SHARP & DOHME LLC 2014-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140249130-A1 BIPYRIDYLAMINOPYRIDINES AS SYK INHIBITORS SYK, BTK, LCK ALDH1A1 1515/4885KMT2A 2649/4885MAPT 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.